Pune, Maharshtra-based Serum Institute of India (SII) invested over $68 million in UK-based Oxford Biomedica plc, a gene and cell therapy company specializing in the development of gene-based medicines. Serum Life Sciences Ltd, a unit of SII, will pick up a 3.9% stake in Oxford Biomedica as part of the...
Novartis Conducted Clinical Trials in India for Covid Drug Ruxolitinib
Swiss major Novartis sought regulatory approval in India to initiate Phase III clinical trials for its drug, Ruxolitinib used in the treatment of Covid 19. These trials were part of a global study that the company started in May to evaluate the use of Ruxolitinib (sold as Jakavi) for treatment...
U.S. Congressional Delegation Meets P.M. Modi
On Saturday November 13, A U.S. Congressional Delegation lead by Senator John Cornyn, co-founder and co-chair of the Senate caucus on India and Indian Americans, met Prime Minister Modi to discuss regional issues of mutual interest, including those related to South Asia and the Indo-Pacific region. Other members of the...
India’s GDP Rose Over 20% in Q2
India's economy grew at a record pace in the second calendar quarter. Even as the country grappled with a devastating wave of Covid-19, GDP rose 20.1% in the three months to June 30, compared with a record contraction in the same quarter a year earlier. "The record year-on-year rise in...
India Approves DNA Vaccine for Covid-19
Gujarat India based Zydus Cadila's Covid-19 vaccine ZyCoV-D, meant for adults and children aged 12 years and above, was today approved for "restricted use in emergency situation" by the Central Drugs Standard Control Organization (CDSCO) which is India's regulator. The DNA vaccine, developed in partnership with India's Department of Biotechnology,...
U.S. Trade Representative Supports Waiver to Accelerate Covid-19 Vaccine Production
In a move that could help Indian companies ramp up production of Covid-19 vaccines currently developed/marketed by Moderna, Pfizer and Johnson & Johnson, Katherine Tai just released a statement supporting the waiver of Intellectual Property Rights (TRIPs provisions on the World Trade Organization), relating the production of these vaccines Tai,...